Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective
نویسندگان
چکیده
منابع مشابه
Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective
Antineoplastic drugs can be associated with several side effects, including cardiovascular toxicity (CTX). Biochemical studies have identified multiple mechanisms of CTX. Chemoterapeutic agents can alter redox homeostasis by increasing the production of reactive oxygen species (ROS) and reactive nitrogen species RNS. Cellular sources of ROS/RNS are cardiomyocytes, endothelial cells, stromal and...
متن کاملA Novel Insight into the Cardiotoxicity of Antineoplastic Drug Doxorubicin
Doxorubicin is a commonly used antineoplastic agent in the treatment of many types of cancer. Little is known about the interactions of doxorubicin with cardiac biomolecules. Serious cardiotoxicity including dilated cardiomyopathy often resulting in a fatal congestive heart failure may occur as a consequence of chemotherapy with doxorubicin. The purpose of this study was to determine the effect...
متن کامل1 Drug - induced mitochondrial dysfunction and cardiotoxicity 1
Drug-induced mitochondrial dysfunction and cardiotoxicity 1 Zoltán V. Varga, Peter Ferdinandy, Lucas Liaudet, Pál Pacher 2 3 4 Laboratory of Cardiovascular Physiology and Tissue Injury, National Institutes of 5 Health/NIAAA, Bethesda, MD, USA. 6 Cardiometabolic Research Group, Department of Pharmacology and Pharmacotherapy, 7 Semmelweis University, Budapest, Hungary 8 Pharmahungary Group, Szege...
متن کاملEarly Tumoricidal Drug-Induced Cardiotoxicity Determination: Possibilities of Biological Markers
Cardiotoxicity due to tumoricidal drug use is defined as an asymptomatic reduction in left ventricular (LV) ejection fraction (EF) of ≥10% to <55% or as a reduction of the LVEF of ≥5% to <55% with symptoms of heart failure (HF). The implementation in routine practices the highly tumoricidal anthracycline drugs, taxanes, and trastuzumab cause progressive LV dysfunction and symptomatic HF in dose...
متن کاملDetermination of early tumoricidal drug-induced cardiotoxicity with biological markers
Cardiotoxicity due to tumoricidal drug use is defined as an asymptomatic reduction in left ventricular (LV) ejection fraction (EF) of ≥ 10% to <55% or as a reduction of the LVEF of ≥ 5% to <55% with symptoms of heart failure (HF). The implementation in routine practices the highly tumoricidal anthracycline drugs, taxanes, and trastuzumab cause progressive LV dysfunction and symptomatic HF in do...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Frontiers in Physiology
سال: 2018
ISSN: 1664-042X
DOI: 10.3389/fphys.2018.00167